NIH Seeks Comments on Mental Health Archive
Published Date: 6/3/2026
Notice
Summary
The National Institute of Mental Health (NIMH) is asking for a 30-day public comment period to review and approve their data collection process for the Mental Health Data Archive. This affects researchers and anyone who shares mental health data with NIMH. Comments are due by June 3, 2026, and there’s no new cost involved—just keeping things clear and up-to-date!
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
Researchers' 90‑Minute Data Forms
If you are a researcher who submits data to or requests access from the NIMH Data Archive (NDA), you must complete either a Data Submission Agreement (DSA) or a Data Use Certification (DUC). Each response takes about 90 minutes; there are an estimated 300 submitting researchers and 950 access-requesting researchers, for a total annualized burden of 1,875 hours. There are no monetary costs to respondents, OMB approval is requested for 3 years, the current control expires 2026-06-30, and comments are due by June 3, 2026.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-18191, Submission for OMB Review; 30-Day Comment Request Data and Specimen Hub (DASH) (Eunice Kennedy Shriver National Institute of Child Health and Human Development)
The National Institutes of Health (NIH) is asking for public feedback on their Data and Specimen Hub (DASH), which helps researchers share important health data. This is a quick 30-day review to make sure the information collection is clear and useful. If you’re involved in health research or data sharing, your input by October 8, 2026, can help shape how DASH works without costing extra money or time.
2026-17899, Proposed Collection; 60-Day Comment Request; Assurance (Interinstitutional, Foreign, and Domestic) and Annual Report (Office of the Director)
The NIH wants your thoughts on their plan to keep track of animal research safety through yearly reports and assurances from institutions, both in the U.S. and abroad. This helps make sure labs follow the rules and protect animals, with no new costs or big changes expected. You’ve got until October 2, 2026, to share your feedback and help improve the process!
2026-17687, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in October 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, ensuring fair and confidential decisions. Scientists applying for grants in genetics, molecular sciences, oral health, and cancer research are the ones affected, with no direct cost changes announced.
2026-17438, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings in late September 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers applying for funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
Previous / Next Documents
Previous: 2026-11043, Initiation of Section 301 Investigation and Request for Public Comments: Vietnam's Acts, Policies, and Practices Related to Intellectual Property Protection and Enforcement
The U.S. is launching an investigation into Vietnam for not protecting intellectual property rights fairly, which affects American businesses relying on these protections. This could lead to changes in trade rules or penalties if Vietnam doesn’t improve. Public comments are open until July 2, 2026, so anyone interested can share their thoughts before decisions are made.
Next: 2026-11046, Vanda Pharmaceuticals, Inc.; Grant of Hearing Request Regarding a Proposal To Refuse To Approve a Supplemental New Drug Application for HETLIOZ (Tasimelteon)
Vanda Pharmaceuticals asked the FDA to approve a new use for their sleep drug HETLIOZ to treat jet lag, but the FDA said no and now there’s a public hearing to decide what’s next. This affects Vanda, travelers hoping for a jet lag fix, and could delay the drug’s availability while money and time are on the line. The hearing starts July 20, 2026, so mark your calendars!